Study summary · research use only
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review discusses stable gastric pentadecapeptide BPC 157, previously used in ulcerative colitis and multiple sclerosis trials with no reported toxicity (LD1 not achieved), focusing on skin wound therapy including incisional/excisional wounds, deep burns, diabetic ulcers, and alkali burns. In rats, BPC 157 was associated with healing of cutaneous and other tissue wounds (colocutaneous, gastrocutaneous, esophagocutaneous, duodenocutaneous, vesicovaginal, rectovaginal) via resolution of vessel constriction, the platelet plug, the fibrin mesh, and the clot, and with counteracting bleeding from amputation and anticoagulant use and with attenuating arterial and venous thrombosis. The authors note BPC 157 rapidly increased gene expression in rat excision skin wounds, which they suggest may extend to healing in other tissues including the gastrointestinal tract, tendon, ligament, muscle, bone, nerve, spinal cord, cornea, and blood vessels.
Abstract
Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin wound therapy, incisional/excisional wound, deep burns, diabetic ulcers, and alkali burns, which may be generalized to the other tissues healing. Recent Advances: BPC 157 has practical applicability (given alone, with the same dose range, and same equipotent routes of application, regardless the injury tested). Critical Issues: By simultaneously curing cutaneous and other tissue wounds (colocutaneous, gastrocutaneous, esophagocutaneous, duodenocutaneous, vesicovaginal, and rectovaginal) in rats, the potency of BPC 157 is evident. Healing of the wounds is accomplished by resolution of vessel constriction, the primary platelet plug, the fibrin mesh which acts to stabilize the platelet plug, and resolution of the clot. Thereby, BPC 157 is effective in wound healing much like it is effective in counteracting bleeding disorders, produced by amputation, and/or anticoagulants application. Likewise, BPC 157 may prevent and/or attenuate or eliminate, thus, counteract both arterial and venous thrombosis. Then, confronted with obstructed vessels, there is circumvention of the occlusion, which may be the particular action of BPC 157 in ischemia/reperfusion. Future Directions: BPC 157 rapidly increases various genes expression in rat excision skin wound. This would define the healing in the other tissues, that is, gastrointestinal tract, tendon, ligament, muscle, bone, nerve, spinal cord, cornea (maintained transparency), and blood vessels, seen with BPC 157 therapy.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.